The irreversible narcotic antagonistic and reversible agonistic properties of the fumaramate methyl ester derivative of naltrexone
- 1 April 1981
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 70 (4), 445-451
- https://doi.org/10.1016/0014-2999(81)90355-1
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- A novel opioid receptor site directed alkylating agent with irreversible narcotic antagonistic and reversible agonistic activitiesJournal of Medicinal Chemistry, 1980
- Heterogeneity of Opiate-Receptor InteractionPharmacology, 1980
- Chloroxymorphamine, an Opioid Receptor Site-Directed Alkylating Agent Having Narcotic Agonist ActivityScience, 1979
- Opiate Receptors and Opioid PeptidesAnnual Review of Neuroscience, 1979
- Synthesis and pharmacologic characterization of an alkylating analog chlornaltrexamine, of naltrexone with ultralong-lasting narcotic antagonist propertiesJournal of Medicinal Chemistry, 1979
- 6.beta.-[N,N-Bis(2-chloroethyl)amino]-17-(cyclopropylmethyl)-4,5.alpha.-epoxy-3,14-dihydroxymorphinan (chloranaltrexamine), a potent opioid receptor alkylating agent with ultralong narcotic antagonist activityJournal of Medicinal Chemistry, 1978
- The Opiate ReceptorsAnnual Review of Pharmacology and Toxicology, 1978
- Endogenous opioid peptides: multiple agonists and receptorsNature, 1977
- Quantitative studies on the antagonism by naloxone of some narcotic and narcotic‐antagonist analgesicsBritish Journal of Pharmacology, 1970
- Stereochemical Factors and Receptor Interactions Associated with Narcotic AnalgesicsJournal of Pharmaceutical Sciences, 1966